Moreover, our overall study shows the impact of post-translationally modulated PTEN in KSHV-infected cells, which, in turn, makes these cells the target point for mTOR kinase inhibitors and strongly indicates the fact that these group of drugs are the best fit against this type of virus-infected cancer cells with PTM (post translational modification). Here, PTEN is linked to cancer.